Xeno Transplants Stock Fundamentals
| XENO Stock | USD 0.0001 0.00 0.00% |
Xeno Transplants fundamentals help investors to digest information that contributes to Xeno Transplants' financial success or failures. It also enables traders to predict the movement of Xeno Stock. The fundamental analysis module provides a way to measure Xeno Transplants' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Xeno Transplants stock.
As of the 11th of December 2024, Total Operating Expenses is likely to grow to about 308.7 K, while Selling General Administrative is likely to drop about 166.3 K. Xeno | Select Account or Indicator |
Xeno Transplants Company Total Debt Analysis
Xeno Transplants' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Xeno Transplants Total Debt | 21.56 K |
Most of Xeno Transplants' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Xeno Transplants is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Based on the latest financial disclosure, Xeno Transplants has a Total Debt of 21.56 K. This is 100.0% lower than that of the Biotechnology sector and 99.99% lower than that of the Health Care industry. The total debt for all United States stocks is 100.0% higher than that of the company.
Xeno Transplants Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Xeno Transplants's current stock value. Our valuation model uses many indicators to compare Xeno Transplants value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Xeno Transplants competition to find correlations between indicators driving Xeno Transplants's intrinsic value. More Info.Xeno Transplants is rated fifth in current valuation category among its peers. It is rated first in price to earning category among its peers . The ratio of Current Valuation to Price To Earning for Xeno Transplants is about 121,091 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Xeno Transplants' earnings, one of the primary drivers of an investment's value.Xeno Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Xeno Transplants' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Xeno Transplants could also be used in its relative valuation, which is a method of valuing Xeno Transplants by comparing valuation metrics of similar companies.Xeno Transplants is currently under evaluation in total debt category among its peers.
Xeno Fundamentals
| Current Valuation | 363.27 K | ||||
| Price To Earning | 3.00 X | ||||
| Price To Book | 10.92 X | ||||
| Net Income | (256.37 K) | ||||
| Cash And Equivalents | 261 | ||||
| Total Debt | 21.56 K | ||||
| Current Ratio | 0.15 X | ||||
| Book Value Per Share | 0 X | ||||
| Cash Flow From Operations | (6.56 K) | ||||
| Beta | -28.5 | ||||
| Market Capitalization | 64.58 K | ||||
| Total Asset | 641.41 K | ||||
| Retained Earnings | (46.35 K) | ||||
| Working Capital | (946 K) | ||||
| Current Asset | 100 K | ||||
| Current Liabilities | 1.05 M | ||||
| Net Asset | 641.41 K |
About Xeno Transplants Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Xeno Transplants's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xeno Transplants using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xeno Transplants based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year |
Pair Trading with Xeno Transplants
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Xeno Transplants position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xeno Transplants will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Xeno Transplants could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Xeno Transplants when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Xeno Transplants - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Xeno Transplants to buy it.
The correlation of Xeno Transplants is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Xeno Transplants moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Xeno Transplants moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Xeno Transplants can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Xeno Transplants Piotroski F Score and Xeno Transplants Altman Z Score analysis. To learn how to invest in Xeno Stock, please use our How to Invest in Xeno Transplants guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xeno Transplants. If investors know Xeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xeno Transplants listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Xeno Transplants is measured differently than its book value, which is the value of Xeno that is recorded on the company's balance sheet. Investors also form their own opinion of Xeno Transplants' value that differs from its market value or its book value, called intrinsic value, which is Xeno Transplants' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xeno Transplants' market value can be influenced by many factors that don't directly affect Xeno Transplants' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xeno Transplants' value and its price as these two are different measures arrived at by different means. Investors typically determine if Xeno Transplants is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xeno Transplants' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.